InspireMD Inc. (NSPR)
NASDAQ · Healthcare
InspireMD Inc. EBITDA 2009–2025
InspireMD Inc. annual/quarterly ebitda history and growth rate from 2009 to 2019. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- InspireMD Inc. ebitda for the quarter ending March 31, 2019 was -3.1 M, a 61.87% increase year-over-year.
- InspireMD Inc. ebitda for the twelve months ending March 31, 2019 was -9.4 M, a 43.48% decrease year-over-year.
- InspireMD Inc. annual ebitda for 2025 was 426.4 M, a 72.98% increase from 2024.
- InspireMD Inc. annual ebitda for 2024 was 246.5 M, a 16.90% increase from 2023.
- InspireMD Inc. annual ebitda for 2023 was 210.9 M, a 24.56% increase from 2022.
- InspireMD Inc. annual ebitda for 2022 was 169.3 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
InspireMD Inc. EBITDA — FAQ
InspireMD Inc. (NSPR) ebitda over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NSPR's ebitda history?
The chart and table above show InspireMD Inc.'s ebitda by year and by quarter, including the growth rate.